Reshape Lifesciences Inc Share Price Nasdaq
Equities
US7611234052
Advanced Medical Equipment & Technology
Sales 2024 * | 9.99M 834M | Sales 2025 * | 11.99M 1B | Capitalization | 3.8M 318M |
---|---|---|---|---|---|
Net income 2024 * | -6M -501M | Net income 2025 * | -5M -417M | EV / Sales 2024 * | 0.38 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.32 x |
P/E ratio 2024 * |
-0.36
x | P/E ratio 2025 * |
-0.45
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.83% |
Latest transcript on Reshape Lifesciences Inc
Managers | Title | Age | Since |
---|---|---|---|
Paul Hickey
CEO | Chief Executive Officer | 59 | 01/20/01 |
Director of Finance/CFO | 63 | 15/21/15 | |
Dov Gal
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Blackford
BRD | Director/Board Member | 66 | 01/16/01 |
Dan Gladney
CHM | Chairman | 70 | 01/15/01 |
Director/Board Member | 70 | 15/21/15 |
1st Jan change | Capi. | |
---|---|---|
+7.72% | 220B | |
+6.09% | 183B | |
+10.57% | 133B | |
+24.35% | 107B | |
-0.95% | 63.05B | |
+11.30% | 51.74B | |
+4.81% | 50.47B | |
-0.96% | 40.91B | |
+24.15% | 31.91B |